Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations.
Fürstenau M, Thus YJ, Robrecht S, Mellink CHM, van der Kevie-Kersemaekers AM, Dubois J, von Tresckow J, Patz M, Gregor M, Thornton P, Staber PB, Tadmor T, Levin MD, da Cunha-Bang C, Schneider C, Poulsen CB, Illmer T, Schöttker B, Janssens A, Christiansen I, Nösslinger T, Baumann M, Hebart H, Gaska T, Regelink JC, Dompeling EC, Lindström V, Juliusson G, Widmer A, Goede J, Goldschmidt N, Simon F, De Silva N, Fink AM, Fischer K, Wendtner CM, Ritgen M, Brüggemann M, Tausch E, Spaargaren M, Eldering E, Stilgenbauer S, Niemann CU, Hallek M, Eichhorst B, Kreuzer KA, Kater AP. Fürstenau M, et al. Among authors: poulsen cb. Blood. 2023 Aug 3;142(5):446-459. doi: 10.1182/blood.2023019634. Blood. 2023. PMID: 37172204 Clinical Trial.
The Danish National Chronic Lymphocytic Leukemia Registry.
da Cunha-Bang C, Geisler CH, Enggaard L, Poulsen CB, de Nully Brown P, Frederiksen H, Bergmann OJ, Pulczynski EJ, Pedersen RS, Nielsen LH, Christiansen I, Niemann CU. da Cunha-Bang C, et al. Among authors: poulsen cb. Clin Epidemiol. 2016 Oct 25;8:561-565. doi: 10.2147/CLEP.S99486. eCollection 2016. Clin Epidemiol. 2016. PMID: 27822100 Free PMC article. Review.
Venous thromboembolism in chronic lymphocytic leukemia: a Danish nationwide cohort study.
Gade IL, Riddersholm SJ, Christiansen I, Rewes A, Frederiksen M, Enggaard L, Poulsen CB, Bergmann OJ, Gillström DB, Pedersen RS, Nielsen L, Eriksen HH, Torp-Pedersen C, Kristensen SR, Severinsen MT. Gade IL, et al. Among authors: poulsen cb. Blood Adv. 2018 Nov 13;2(21):3025-3034. doi: 10.1182/bloodadvances.2018023895. Blood Adv. 2018. PMID: 30425066 Free PMC article.
IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment: a Danish nationwide population-based study.
Rotbain EC, Frederiksen H, Hjalgrim H, Rostgaard K, Egholm GJ, Zahedi B, Poulsen CB, Enggard L, da Cunha-Bang C, Niemann CU. Rotbain EC, et al. Among authors: poulsen cb. Haematologica. 2020 Jun;105(6):1621-1629. doi: 10.3324/haematol.2019.220194. Epub 2019 Oct 3. Haematologica. 2020. PMID: 31582540 Free PMC article.
Richter's transformation in patients with chronic lymphocytic leukaemia: a Nationwide Epidemiological Study.
Ben-Dali Y, Hleuhel MH, da Cunha-Bang C, Brieghel C, Poulsen CB, Clasen-Linde E, Bentzen HHN, Frederiksen H, Christiansen I, Nielsen LH, Enggaard L, Helleberg M, Clausen M, Frederiksen M, Pedersen RS, Niemann CU, Andersen MA. Ben-Dali Y, et al. Among authors: poulsen cb. Leuk Lymphoma. 2020 Jun;61(6):1435-1444. doi: 10.1080/10428194.2020.1719092. Epub 2020 Feb 7. Leuk Lymphoma. 2020. PMID: 32031030
Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia.
Niemann CU, Levin MD, Dubois J, Kersting S, Enggaard L, Veldhuis GJ, Mous R, Mellink CHM, Dobber JA, Poulsen CB, Frederiksen H, Janssens A, Schjødt I, Dompeling EC, Ranti J, Mattsson M, Bellido M, Tran HTT, Nasserinejad K, Kater AP. Niemann CU, et al. Among authors: poulsen cb. Blood. 2021 Feb 25;137(8):1117-1120. doi: 10.1182/blood.2020008608. Blood. 2021. PMID: 33027809 Free article. Clinical Trial. No abstract available.
Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION): primary analysis of an open-label, randomised, phase 2 trial.
Kater AP, Levin MD, Dubois J, Kersting S, Enggaard L, Veldhuis GJ, Mous R, Mellink CHM, van der Kevie-Kersemaekers AF, Dobber JA, Poulsen CB, Frederiksen H, Janssens A, Schjødt I, Dompeling EC, Ranti J, Brieghel C, Mattsson M, Bellido M, Tran HTT, Nasserinejad K, Niemann CU. Kater AP, et al. Among authors: poulsen cb. Lancet Oncol. 2022 Jun;23(6):818-828. doi: 10.1016/S1470-2045(22)00220-0. Lancet Oncol. 2022. PMID: 35654052 Clinical Trial.
Prognostic significance of metallothionein in B-cell lymphomas.
Poulsen CB, Borup R, Borregaard N, Nielsen FC, Møller MB, Ralfkiaer E. Poulsen CB, et al. Blood. 2006 Nov 15;108(10):3514-9. doi: 10.1182/blood-2006-04-015305. Epub 2006 Jul 25. Blood. 2006. PMID: 16868254 Free article.
Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy.
Baech J, Severinsen MT, Øvlisen AK, Frederiksen H, Vestergaard P, Torp-Pedersen C, Jørgensen J, Clausen MR, Poulsen CB, Brown P, Gang AO, Pedersen RS, Ekström Smedby K, Eloranta S, Jakobsen LH, El-Galaly TC. Baech J, et al. Among authors: poulsen cb. Blood Adv. 2022 Aug 9;6(15):4427-4435. doi: 10.1182/bloodadvances.2021006859. Blood Adv. 2022. PMID: 35679481 Free PMC article.
72 results